Ancode ApS: Financial statements 2018
CVR: 32334865
Ancode ApS (CVR 32334865) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 189,709 and a net result of DKK -23,113 compared with DKK -261,691 the year before. That is a decrease of 85.6% compared with the year before. Equity amounted to DKK 34,499. The solvency ratio was 0.2%.
- Gross Profit
- 189,709 kr.
- Profit/Loss
- -23,113 kr.
- Equity
- 34,499 kr.
- Total Assets
- 15,831,637 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 190 t. | -23 t. | 34 t. | 0 |
| 2017 | - | 1.3 mio. | -262 t. | 58 t. | 0 |
| 2016 | - | 874 t. | -716 t. | 319 t. | 0 |
| 2015 | - | 1.7 mio. | 916 t. | 1 mio. | - |
| 2014 | - | 532 t. | 69 t. | 119 t. | - |
Keep an eye on Ancode ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Ancode ApS has published its annual report for 2017. Gross profit came to DKK 1,313,453, and the net result was DKK -261,691.
As of July 10, 2018, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Ancode ApS.
As of January 19, 2018, Martin Lampe is registered as liquidator of Ancode ApS.
As of January 19, 2018, Henry Vincenty has stepped down as director of Ancode ApS.
On January 19, 2018, Ancode ApS entered liquidation.
About Ancode ApS
Ancode ApS was a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2014 and dissolved in 2020. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 3 employees. In 2019, the company reported a gross profit of DKK -317,528 and a net result of DKK -390,668 compared with DKK -23,113 the year before. Equity amounted to DKK -356,168.
